Jeollabuk-do, South Korea

Ki-Young Lee


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ki-Young Lee: Innovator in Antimicrobial Peptide Research

Introduction

Ki-Young Lee is a prominent inventor based in Jeollabuk-do, South Korea. He has made significant contributions to the field of antimicrobial research, particularly through his innovative work on peptide analogs derived from abalone. His research focuses on developing effective antimicrobial agents that can be utilized in pharmaceutical applications.

Latest Patents

Ki-Young Lee holds a patent for an antimicrobial peptide analog that is derived from abalone. This patent describes a pharmaceutical composition that includes the peptide, which is designed based on hdMolluscidin, a peptide sourced from the gill of abalone. The innovative aspect of this peptide analog lies in its commercial viability, achieved by reducing the number of amino acids while maintaining superior antimicrobial activity, high membrane permeability, and low hemolytic activity. He has 1 patent to his name.

Career Highlights

Ki-Young Lee is affiliated with the Industry-Academic Cooperation Foundation at Kunsan National University. His work in this institution has allowed him to bridge the gap between academic research and practical applications in the industry. His dedication to advancing antimicrobial research has positioned him as a key figure in this field.

Collaborations

Throughout his career, Ki-Young Lee has collaborated with notable colleagues, including Jung-Kil Seo and Sang-man Cho. These collaborations have further enriched his research and contributed to the development of innovative solutions in antimicrobial therapies.

Conclusion

Ki-Young Lee's contributions to antimicrobial peptide research highlight his role as an influential inventor in the field. His innovative approaches and collaborations continue to pave the way for advancements in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…